CAMBRIDGE, Mass., April 27, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), today announced that its partner, Pfizer, has presented preclinical data on PF-08052666 (HBM9033; SGN-MesoC2), a first-in-class...
Hence then, the article about nona biosciences partner pfizer presents preclinical data on top1i based adc targeting msln at aacr annual meeting 2025 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Nona Biosciences' Partner Pfizer Presents Preclinical Data on TOP1i-Based ADC Targeting MSLN at AACR Annual Meeting 2025 )
Also on site :
- The Nord Stream narrative explosion: Why you’ve only read half the story
- World Cup hydration breaks: Ads worth $250m in USA alone, so are they here to stay?
- Exclusive: Azzi Fudd joins Project B, the international league chasing a billion-dollar opportunity in global basketball